Chemoinformaics analysis of WOGONIN-7-O-BETA-D-GLUCURONIDE-METHYL-ESTER
| Molecular Weight | 474.418 | nRot | 5 |
| Heavy Atom Molecular Weight | 452.242 | nRig | 25 |
| Exact Molecular Weight | 474.116 | nRing | 4 |
| Solubility: LogS | -3.899 | nHRing | 2 |
| Solubility: LogP | 1.8 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 61.9014 |
| nHD | 4 | BPOL | 32.4866 |
| QED | 0.381 |
| Synth | 3.937 |
| Natural Product Likeliness | 1.657 |
| NR-PPAR-gamma | 0.835 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.029 |
| Pgp-sub | 0.373 |
| HIA | 0.397 |
| CACO-2 | -5.87 |
| MDCK | 0.0000384 |
| BBB | 0.299 |
| PPB | 0.757392 |
| VDSS | 0.939 |
| FU | 0.189368 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.729 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.221 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.467 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.184 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.071 |
| CL | 3.373 |
| T12 | 0.304 |
| hERG | 0.015 |
| Ames | 0.574 |
| ROA | 0.034 |
| SkinSen | 0.034 |
| Carcinogencity | 0.141 |
| EI | 0.008 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.819 |
| Antiviral | Yes |
| Prediction | 0.948758 |